Publications (original articles or review articles) published in 2023 from OUS - Rheumatology Research Group
21 publications found
Cardiac Involvement in Systemic and Local Vasculitides: The Value of Noninvasive Multimodality Imaging
Curr Probl Cardiol, 48 (8), 101718 (in press)
DOI 10.1016/j.cpcardiol.2023.101718, PubMed 37003450
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Rheumatol Int, 43 (6), 1055-1065
DOI 10.1007/s00296-023-05308-3, PubMed 36933069
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Rheumatology (Oxford), 62 (5), 1887-1894
DOI 10.1093/rheumatology/keac478, PubMed 35997556
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
Autoimmun Rev, 22 (4), 103290
DOI 10.1016/j.autrev.2023.103290, PubMed 36746368
Consensus Sonographic Definitions of Tenosynovitis in Children
Arthritis Care Res (Hoboken) (in press)
DOI 10.1002/acr.25159, PubMed 37221153
Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead152, PubMed 37004177
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Rheumatology (Oxford), 62 (SI), SI91-SI100
DOI 10.1093/rheumatology/keac405, PubMed 35904554
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
Rheumatology (Oxford), 62 (SI), SI54-SI63
DOI 10.1093/rheumatology/keac363, PubMed 35731139
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford), 62 (4), 1559-1567
DOI 10.1093/rheumatology/keac533, PubMed 36099040
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00602-2022, PubMed 37260456
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002859, PubMed 36796874
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead111, PubMed 36929918
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
Rheumatology (Oxford), 62 (SI), SI43-SI53
DOI 10.1093/rheumatology/keac325, PubMed 35640959
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology (Oxford), 62 (6), 2178-2188
DOI 10.1093/rheumatology/keac576, PubMed 36222557
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644
Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
Rheumatology (Oxford), 62 (SI2), SI196-SI204
DOI 10.1093/rheumatology/keac293, PubMed 35575380
Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
BMC Pulm Med, 23 (1), 51
DOI 10.1186/s12890-023-02336-4, PubMed 36732734
Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation
Arthritis Rheumatol, 75 (6), 1021-1027
DOI 10.1002/art.42434, PubMed 36580032
Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002937, PubMed 36963783
Effects of faecal microbiota transplantation on small intestinal mucosa in systemic sclerosis
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/kead014, PubMed 36688692
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
Rheum Dis Clin North Am, 49 (2), 249-262
DOI 10.1016/j.rdc.2023.01.003, PubMed 37028833